EDQM Grants C2 PHARMA CEP Approval for Commercial Sale of Cyclopentolate Hydrochloride
![](/46/pdcnewsitem/12/15/01/c2p_start_about-2.jpg)
C2 Pharma receives the European Directorate for the Quality of Medicines and Healthcare second Certificate of Suitability for Cyclopentolate Hydrochloride, a significant achievement for our dedicated team.
The #cep approved by the EDQM is the second existing approval for Cyclopentolate Hydrochloride and the only approval allowing our #gmp-certified manufacturing site to supply to other markets.
![C-squared PHARMA Limited](https://www.cphi-online.com/c250877th_S-comp250877.jpg)
Position your company at the heart of the global Pharma industry with a CPHI Online membership
-
Your products and solutions visible to thousands of visitors within the largest Pharma marketplace
-
Generate high-quality, engaged leads for your business, all year round
-
Promote your business as the industry’s thought-leader by hosting your reports, brochures and videos within your profile
-
Your company’s profile boosted at all participating CPHI events
-
An easy-to-use platform with a detailed dashboard showing your leads and performance